The summary of original retrospective studies on predictors of VAs or SCD in MVP patients
| Study | Year | No. of AMVP patients | Female (%) | Age (years) | AMVP risk factors |
|---|---|---|---|---|---|
| Akcay et al. [31] | 2010 | 30 | 72% | 42 ± 15 36 ± 13 | Mitral anterior leaflet length Enhanced QTcD |
| Sriram et al. [50] | 2013 | 10 | 90% | 33 ± 16 | BiMVP Female sex PVC Biphasic/inverted inferior T waves |
| Basso et al. [2] | 2015 | 30 | 73% | 41 ± 12 | Fibrosis of PMs and inferobasal LV free wall, detected by LGE on CMR |
| Bui et al. [37] | 2017 | 14 | 29% | 55 ± 13 | Reduced postcontrast T1 times suggestive of diffuse myocardial fibrosis |
| Garbi et al. [53] | 2018 | 68 | 48% | 38 ± 15 | Bileaflet prolapse Mitralannulus dilatation Degenerative features of the myocytes Right ventricular fibrosis |
| Ermakov et al. [57] | 2019 | 32 | 53 | 57 ± 13 | Increased DM by speckle-tracking echocardiography |
| Essayagh et al. [23] | 2020 | 257 | 39 | 68 ± 15 | ST-T changes MAD LAVI LVESD QTc interval BiMVP MR grade |
| Pavon et al. [36] | 2021 | 30 | 40 | 50 ± 17 | MAD ECV > 27% |
| Vairo et al. [56] | 2023 | 22 | 86 | 44 ± 14 | AP diameter/AML length ratio The mitral valve annulus indexed area The inferolateral basal S3 velocity The AML length The basal/mid-ventricular segments DM |
